Traws Pharma (TRAW) Stock: Buy, Sell, or Hold?
TRAW - Traws Pharma, Inc. Common Stock
$0.58
0.00 (0.57%)
▲
5d:
+16.46%
30d:
-1.29%
90d:
-30.95%
HOLD
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When TRAW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TRAW shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TRAW shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TRAW is currently trading at $0.58, which is considered fair relative to its 30-day fair value range of $0.52 to $0.57.
Technical Outlook: Technically, TRAW is in a strong downtrend. Immediate support is located at $0.48, while resistance sits at $0.70.
Market Sentiment: TRAW scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.00 (+72.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TRAW is in a strong downtrend. Immediate support is located at $0.48, while resistance sits at $0.70.
Market Sentiment: TRAW scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.00 (+72.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.52 -
$0.57
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (68/100)
- BULLISH: Trading 72.7% below Wall St target ($1.00)
- CAUTION: Bottoming setup, but lagging the sector by 12% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.52 -
$0.57
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.48
Resistance Level
$0.70
Current Trend
Strong Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.31
Wall Street Target
$1.00
(+72.7%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 29, 2026 11:01 AM ET
Data refreshes hourly during market hours. Next update: 12:01 PM
Data refreshes hourly during market hours. Next update: 12:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRAW showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 48 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 54 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$21 | 56 HOLD |